drugset / Trial / NCT03661892
Pilot, Syndros, Decreasing Use of Opioids in Breast Cancer Subjects With Bone Mets
NaSingle-groupOpen-labelTreatment
Summary
In patients with cancer induced bone pain, addition of Syndros will improve pain relief and decrease opioid requirement.
Timeline
- Start
- 2018-12-19
- Primary completion
- 2020-10-30
- Completion
- 2021-04-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dronabinol | Other / unclassified | 8.4 mg | Oral |